저자: 미상 · 외국인
요약 보기
고(故) 라케시 준준왈라의 포트폴리오를 리뷰하며 타이탄, 스타헬스, 메트로브랜드, 페더럴뱅크, 캐나라뱅크, 크리실, 카르뱅크 등 장기 복리 보유 종목을 소개. 보유가치 상위 종목과 실적·주가 성장 수치(타이탄 10년 ROE ~29%, 이익성장 22%, 주가 CAGR 27% 등)를 근거로 제시. 구체적 향후 가격 전망은 없음.
다듬은 글
Friends, in today's video we are going to review the portfolio of Rakesh Jhunjhunwala ji. Rakesh Jhunjhunwala started his investment journey many decades ago and one interesting thing about it is that you get to see a lot of compounders in his portfolio. Such stocks which have been lying in their portfolio for the last 20-20 years.
But till now they are giving them the benefit of compounding. So in today's video we will talk in detail about his portfolio. Which stocks form the majority chunk of their portfolio. Although he is not in this world right now. Rest in peace to him. But his family is maintaining his portfolio and this is the best thing about the stock market that your legacy can continue even after you are gone and the same thing is visible in the portfolio of Rakesh Jhunjwala ji.
First of all, let us go over their portfolio to see which are the stocks that actually form the biggest part of their portfolio. So if you look at his portfolio, you will see a very interesting thing here that in 2015 and 2016, his net worth was around Rs 8900 crore. From there, this net worth has increased to around Rs 71,000 crore as of today.
This net worth tells you how compounding can work magic for you and such compounding is not called the seventh wonder of the world. If we look at their holdings, then if you arrange the filters in descending order according to their holding value, then first of all you will get those companies where the value of Rakesh Jhunjhunwala ji's holding is very high.
The first name that comes in it is Titan. However, it was Titan that made Rakesh Jhunjhunwala ji, that Titan company had the biggest role in making him. He took over the Titan company many decades ago. When the value of the company was nothing. People did not know his potential. But that's the thing that makes up the majority of their portfolio chunks at number one.
Number one is their holding. His holdings are around Rs 22,000 crore. And there is no need to say much about Titan. Because if you go to look at its fundamentals and technicals, you will get to know how the company has increased its investment on year on year basis. So the stock which was around ₹13 a few years ago in 2005, is worth around ₹4500 crores today.
In that I am not adding dividend and bonus to you. Along with that, you understand one thing that if you look at its component profit growth, then it has grown at 22% in 10 years. You also see a 23% increase in sales growth over 10 years on a year-on-year basis. The stock price has grown at a CAGR of 27% and the return on equity is around 29% with a 10-year average.
When you have such stock lying around, you get a good night's sleep. Secondly, they have stock ISL which is also called Venture Knowledge. This stock is actually their recent one. This does not mean that he had bought this stock of Titan level many years ago. And the Jhujhunwala family also has a huge stake in it.
But if you go to see their stake, then here you come to know that Jhunjhunwala Trust Jhunjhunwala Family owns a lot of this stock. So basically this stock, although its value is also quite high. But being a promoter of the company, this stock actually forms a huge portion of his portfolio. And friends, this stock basically works in the health care sector.
If you go to see its maximum chart, the stock has not made any major upturn as such. The stock still has a lot to prove. So the business is new but he himself means he is a very big part of it. He holds approximately 49% of the company. So you can look at that company as a promoter. After that, he has Star Health, whose holding value is around Rs 6000 crore.
This is also a very good business. If you go to see the fundamentals of Star Health especially, then you will come to know how strong business this company does. However, if you look at the maximum chart, you will realize that there has not been much upheaval since 2021. But you know, if you look at their CAGR or if you look at their profit growth, you can see very good growth.
If we also look at their U NOW shareholding pattern, FI had a huge stake in this stock around 2023. But still this stock is owned by FI and DI in large numbers. And this company works in the insurance sector. So definitely this company will get huge benefits in future when insurance penetration happens in India.
After that comes Metro Brands which you might have seen many times inside malls. Metro Brands owns many small businesses, both small and large, within its malls. So Metro Brands is a brand like fashion retailer Fashion Retail. It basically deals in Indian footwear and accessories. If you look at its maximum chart, then this stock has also shown a very good upward movement from 2021 till now.
But it is not that if you compare Titan then all the other stocks in its portfolio appear pale to you. But definitely the business is very strong. Because if you look at their profit, there is a growth of 44% within 5 years. You know, if you look at the compounded sales growth over the years, it is 29% in 5 years.
So this tells you how the retail businesses in India are shifting and this is a very good portion of their portfolio and this is also a very good brand and Metro brand, when you go to the mall, you must have seen that many brands are available with them inside their shops. After that, there is Concad Biotech, which you know owns a stock worth Rs 3287 crore in their portfolio and if you look at their business, then basically this stock works in the biotech company within the life sciences.
Its founding was in 1984. If you look at the maximum chart, then the stock has not shown any such big growth, you know much, or many things like that on the chart, but if you look at all the stocks in their portfolio, then one of the best things is that their compounded sales growth and compounded profit growth in the long term is around 20% on average or your average is around 15 to 18%, which is a very important factor for making any portfolio compounded and for making any portfolio bigger, so this is also there which is around 24% in their portfolio.
They own this company. After that, there is 40 Health Care. 40 Health Care is also very old in their portfolio. 40 Health Care definitely. The way the health sector is growing in India and insurance is penetrating, then definitely stocks like 40 Healthcare and Hospital will be very important. However, I would like to give a disclaimer that I also have a stake in this company, so definitely take advice from your stock market advisor before selling any stock.
After that there is Tata Motors also. Although the company does not have a very big stake in this stock, it definitely owns a stake of Rs 2000 crore. 1.3% own this company. There is no need to say much about Tata Motors. But definitely because Tata is an Indian brand, but you know, it depends a lot on the raw material cost of Tata Motors.
Federal [nasal sound] Bank is very interesting. Because Federal Bank stock was below ₹100 as far as I remember. Even at that time, it was in Rakesh Jhunjhunwala's portfolio and even today, if you go to see Federal Bank, you can see Federal Bank very well above the price. If you look at the charts of the last 5 years, you will see clear cut exponential growth.
Today it has gone beyond ₹80, ₹90 and even ₹300. So there is no need to say much about Federal Bank. Canara Bank has also performed in this manner. Inside Rakesh Jwala's portfolio. Tata Motors Again here is CRISIL which is very old. It was said a lot about CRISIL that he had identified CRISIL when no one knew about its business.
But Chriselle has also given them very little bonding. Because if you look at the growth of 10 years or even the maximum from around 20056, then from there you can clearly see how well the stock has performed. The fun part of his portfolio is that there are so many great compounders. Kar Bank Obviously Kar Bank I still remember around 2020 the stock of this company was around ₹40.
It has crossed ₹300 as of today and this is what happens when the asset quality of your company is very strong. As I told you, this stock was around ₹12 in 20056 and it was also around ₹40-50 in 2020. From there it has made a huge jump. So you can see very good compounders in their stock. NCC is a very old stock.
There was a time when it performed very well. But even then he did not increase the stake to a very large extent. Even when he was alive, he did not clash and even now you do not see much of this company as a majority chunk of his portfolio. Then after that there are small stocks, friends, we will not take much time with them but I want to tell you that you know, these stocks there, take way back, these are very new businesses, Indian Autos Company Jubil Pharma, Tata Communications, Vkar, Vkar have also got U know approval from FD, these are very important stocks for farmers, JBLT Invia Valstatech Jio Finance Services Brands are some of the stocks in which their new U know, some new stocks have been purchased by their trust.
But if you go to see the majority where actually you know Rakesh Jhunjhunwala, Rakesh Jhunjhunwala ji has made his portfolio through his own choices, then the first name that comes here is Titan, IKS, Star Hth Metro, Ford Healthcare, Federal Bank, Can Bank, CEL, Kars Bank, these were some such stocks, friends, Rakesh Jhunjhunwala ji had invested very early when he was actually in this world and this tells you clearly how important it is to identify good businesses for any stock to move forward, so this was today's video, comment before that, subscribe to the channel, like the video, thank you friends, thank you for watching this video.
Comments 0